History of ROGAINE® Products

Step inside of the story of minoxidil and to its unlikely beginnings. Learn how the ROGAINE® brand turned an unexpected side effect into a life changer for all of those experiencing hereditary hair loss.

Flashback to the fabulous 80s. Amid the irreverent frizz and wild florescence, a sweet, tress-enhancing discovery was made. When people with high blood pressure took minoxidil tablets, they experienced an unexpected side effect--new hairs that started appearing. This finding would end up being a pivotal discovery for millions of Americans experiencing hereditary hair loss. Taking note, scientists began studying use of topical minoxidil solution on the scalp. Soon, results emerged showing us that topical minoxidil could indeed successfully regrow hair.

Around this time, ROGAINE clinical trials began. In 1988, ROGAINE2% Minoxidil Solution for Men debuted as a prescription-only solution to hereditary hair loss. The female version followed in 1992. Four years later, both brands became more widely accessible when they became available over-the-counter at drugstores. A higher-dose, extra-strength version (5%) launched in 1997. Johnson & Johnson acquired ROGAINE in 2006 and rapidly developed an, innovative OTC 5% foam version of ROGAINE brand for men. In 2010, unscented 5% Minoxidil Foam treatment was approved for hereditary hair loss in men. Most recently, in 2014, a once-daily Women's ROGAINE Foam was introduced. Minoxidil is the only topical ingredient approved by the FDA to regrow hair.

ROGAINE® product is the premiere topical brand FDA-approved product to promote hair regrowth. Showcasing 20-plus years of results, ROGAINE® brand has been a long-standing industry leader and remains the #1 dermatologist-recommended hair regrowth brand. With more than 1 in 4 women experiencing hereditary hair loss, you may be surprised at how many have gone on to reclaim their gorgeous locks with a little help from Women’s ROGAINE® products.